Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 198

1.

Clostridium paraputrificum septic arthritis and osteomyelitis of shoulder: A case report and review of literature.

Vijayvargiya P, Garrigos ZE, Rodino KG, Razonable RR, Abu Saleh OM.

Anaerobe. 2019 Oct 1:102105. doi: 10.1016/j.anaerobe.2019.102105. [Epub ahead of print]

PMID:
31585203
2.

Treatment of latent TB Infection and the risk of tuberculosis after solid organ transplantation: Comprehensive review.

Abad CLR, Deziel PJ, Razonable RR.

Transpl Infect Dis. 2019 Sep 21:e13178. doi: 10.1111/tid.13178. [Epub ahead of print] Review.

PMID:
31541575
3.

Differences in Duration and Degree of Cytomegalovirus DNAemia Observed with Two Standardized Quantitative Nucleic Acid Tests and Implications for Clinical Care.

Meesing A, Germer JJ, Yao JD, Gartner ML, Digmann BJ, Razonable RR.

J Infect Dis. 2019 Aug 31. pii: jiz452. doi: 10.1093/infdis/jiz452. [Epub ahead of print]

PMID:
31504626
4.

Safety considerations with current and emerging antiviral therapies for cytomegalovirus infection in transplantation.

El Helou G, Razonable RR.

Expert Opin Drug Saf. 2019 Nov;18(11):1017-1030. doi: 10.1080/14740338.2019.1662787. Epub 2019 Sep 6. Review.

PMID:
31478398
5.

Long-term Outcomes of Patients With Human Herpesvirus 6 Encephalitis.

Fida M, Hamdi AM, Bryson A, Razonable RR, Abu Saleh O.

Open Forum Infect Dis. 2019 Jun 5;6(7):ofz269. doi: 10.1093/ofid/ofz269. eCollection 2019 Jul.

6.

A Fatal Case of Disseminated Microsporidiosis Due to Anncaliia algerae in a Renal and Pancreas Allograft Recipient.

Anderson NW, Muehlenbachs A, Arif S, Bruminhent J, Deziel PJ, Razonable RR, Wilhelm MP, Metcalfe MG, Qvarnstrom Y, Pritt BS.

Open Forum Infect Dis. 2019 Jul 8;6(7):ofz285. doi: 10.1093/ofid/ofz285. eCollection 2019 Jul.

7.

Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review.

El Helou G, Razonable RR.

Infect Drug Resist. 2019 Jun 4;12:1481-1491. doi: 10.2147/IDR.S180908. eCollection 2019. Review.

8.

Antifungal prophylaxis in lung transplant: A survey of United States' transplant centers.

Pennington KM, Yost KJ, Escalante P, Razonable RR, Kennedy CC.

Clin Transplant. 2019 Jul;33(7):e13630. doi: 10.1111/ctr.13630. Epub 2019 Jun 23.

PMID:
31173402
9.

Why do lung transplant patients discontinue triazole prophylaxis?

Pennington KM, Razonable RR, Peters S, Scott JP, Wylam M, Daly RC, Kennedy CC.

Transpl Infect Dis. 2019 Jun;21(3):e13067. doi: 10.1111/tid.13067. Epub 2019 Mar 27.

PMID:
30866168
10.

Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice.

Razonable RR, Humar A.

Clin Transplant. 2019 Sep;33(9):e13512. doi: 10.1111/ctr.13512. Epub 2019 Mar 28.

PMID:
30817026
11.

Destination Joint Spacers, Reinfection, and Antimicrobial Suppression.

Valencia JCB, Abdel MP, Virk A, Osmon DR, Razonable RR.

Clin Infect Dis. 2019 Aug 30;69(6):1056-1059. doi: 10.1093/cid/ciz062.

PMID:
30689767
12.

Application of a New Paradigm for Cytomegalovirus Disease Prevention in Mayo Clinic's First Face Transplant.

Razonable RR, Amer H, Mardini S.

Mayo Clin Proc. 2019 Jan;94(1):166-170. doi: 10.1016/j.mayocp.2018.09.017.

PMID:
30611443
13.

Relationship of Ganciclovir Therapeutic Drug Monitoring with Clinical Efficacy and Patient Safety.

Ritchie BM, Barreto JN, Barreto EF, Crow SA, Dierkhising RA, Jannetto PJ, Tosh PK, Razonable RR.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e01855-18. doi: 10.1128/AAC.01855-18. Print 2019 Mar.

14.

An update on Mycobacterium tuberculosis infection after hematopoietic stem cell transplantation in adults.

Abad CLR, Razonable RR.

Clin Transplant. 2018 Dec;32(12):e13430. doi: 10.1111/ctr.13430. Epub 2018 Nov 11.

PMID:
30347465
15.

Absolute Lymphocyte Count Thresholds: A Simple, Readily Available Tool to Predict the Risk of Cytomegalovirus Infection After Transplantation.

Meesing A, Razonable RR.

Open Forum Infect Dis. 2018 Sep 11;5(10):ofy230. doi: 10.1093/ofid/ofy230. eCollection 2018 Oct.

16.

A survey of infection prevention and control practices among solid organ transplantation centers.

Beam E, Razonable RR.

Am J Infect Control. 2019 Jan;47(1):101-104. doi: 10.1016/j.ajic.2018.06.020. Epub 2018 Oct 5.

PMID:
30293740
17.

Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials.

Chemaly RF, Chou S, Einsele H, Griffiths P, Avery R, Razonable RR, Mullane KM, Kotton C, Lundgren J, Komatsu TE, Lischka P, Josephson F, Douglas CM, Umeh O, Miller V, Ljungman P; Resistant Definitions Working Group of the Cytomegalovirus Drug Development Forum.

Clin Infect Dis. 2019 Apr 8;68(8):1420-1426. doi: 10.1093/cid/ciy696.

PMID:
30137245
18.

Clinical Correlation of Cytomegalovirus Infection With CMV-specific CD8+ T-cell Immune Competence Score and Lymphocyte Subsets in Solid Organ Transplant Recipients.

Meesing A, Abraham RS, Razonable RR.

Transplantation. 2019 Apr;103(4):832-838. doi: 10.1097/TP.0000000000002396.

PMID:
30086091
19.

Donor derived Mycobacterium tuberculosis infection after solid-organ transplantation: A comprehensive review.

Abad CLR, Razonable RR.

Transpl Infect Dis. 2018 Oct;20(5):e12971. doi: 10.1111/tid.12971. Epub 2018 Aug 12. Review.

PMID:
30055041
20.

Pharmacologic and immunologic management of cytomegalovirus infection after solid organ and hematopoietic stem cell transplantation.

Meesing A, Razonable RR.

Expert Rev Clin Pharmacol. 2018 Aug;11(8):773-788. doi: 10.1080/17512433.2018.1501557. Epub 2018 Jul 26. Review.

PMID:
30009675
21.

New Developments in the Management of Cytomegalovirus Infection After Transplantation.

Meesing A, Razonable RR.

Drugs. 2018 Jul;78(11):1085-1103. doi: 10.1007/s40265-018-0943-1. Review.

PMID:
29961185
22.

Drug-resistant cytomegalovirus: clinical implications of specific mutations.

Razonable RR.

Curr Opin Organ Transplant. 2018 Aug;23(4):388-394. doi: 10.1097/MOT.0000000000000541. Review.

PMID:
29794552
23.

Role of letermovir for prevention of cytomegalovirus infection after allogeneic haematopoietic stem cell transplantation.

Razonable RR.

Curr Opin Infect Dis. 2018 Aug;31(4):286-291. doi: 10.1097/QCO.0000000000000459. Review.

PMID:
29746444
24.

Mycobacterium tuberculosis after solid organ transplantation: A review of more than 2000 cases.

Abad CLR, Razonable RR.

Clin Transplant. 2018 Jun;32(6):e13259. doi: 10.1111/ctr.13259. Epub 2018 May 7. Review.

PMID:
29656530
25.

Traveler's Diarrhea Recommendations for Solid Organ Transplant Recipients and Donors.

Beeching NJ, CarratalĂ  J, Razonable RR, Oriol I, Vilela EG.

Transplantation. 2018 Feb;102(2S Suppl 2):S35-S41. doi: 10.1097/TP.0000000000002015. Review. No abstract available.

PMID:
29381576
26.

Cytomegalovirus (CMV) DNA quantification in bronchoalveolar lavage fluid of immunocompromised patients with CMV pneumonia.

Beam E, Germer JJ, Lahr B, Yao JDC, Limper AH, Binnicker MJ, Razonable RR.

Clin Transplant. 2018 Jan;32(1). doi: 10.1111/ctr.13149. Epub 2017 Dec 8.

PMID:
29112278
27.

Cytomegaloviraemia clearance with foscarnet during renal replacement therapy.

Wieruszewski PM, Vijayvargiya P, Wilhelm MP, Razonable RR.

J Antimicrob Chemother. 2018 Feb 1;73(2):548-549. doi: 10.1093/jac/dkx398. No abstract available.

PMID:
29096019
28.

Reply to Davido et al.

Khanna S, Tariq R, Tosh PK, Walker RC, Razonable RR, Pardi DS.

Clin Infect Dis. 2018 Jan 18;66(3):483-485. doi: 10.1093/cid/cix789. No abstract available.

PMID:
29020346
29.

Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection Reduces Recurrent Urinary Tract Infection Frequency.

Tariq R, Pardi DS, Tosh PK, Walker RC, Razonable RR, Khanna S.

Clin Infect Dis. 2017 Oct 30;65(10):1745-1747. doi: 10.1093/cid/cix618.

PMID:
29020210
30.

Comparison of Standardized Cytomegalovirus (CMV) Viral Load Thresholds in Whole Blood and Plasma of Solid Organ and Hematopoietic Stem Cell Transplant Recipients with CMV Infection and Disease.

Dioverti MV, Lahr BD, Germer JJ, Yao JD, Gartner ML, Razonable RR.

Open Forum Infect Dis. 2017 Jul 8;4(3):ofx143. doi: 10.1093/ofid/ofx143. eCollection 2017 Summer.

31.

Fungal Infections After Lung Transplantation.

Kennedy CC, Razonable RR.

Clin Chest Med. 2017 Sep;38(3):511-520. doi: 10.1016/j.ccm.2017.04.011. Epub 2017 May 20. Review.

32.

HHV-6 in liver transplantation: A literature review.

Phan TL, Lautenschlager I, Razonable RR, Munoz FM.

Liver Int. 2018 Feb;38(2):210-223. doi: 10.1111/liv.13506. Epub 2017 Jul 29. Review.

PMID:
28650593
33.

Epidemiology, risk factors, and outcomes of infections in patients undergoing liver transplantation for hilar cholangiocarcinoma.

Ramanan P, Cummins NW, Wilhelm MP, Heimbach JK, Dierkhising R, Kremers WK, Rosen CB, Gores GJ, Razonable RR.

Clin Transplant. 2017 Aug;31(8). doi: 10.1111/ctr.13023. Epub 2017 Jul 5.

PMID:
28573685
34.

Evaluation of COBAS AmpliPrep/COBAS TaqMan CMV Test for use in hematopoietic stem cell transplant recipients.

Ramanan P, Razonable RR.

Expert Rev Mol Diagn. 2017 Jul;17(7):633-639. doi: 10.1080/14737159.2017.1325737. Epub 2017 May 15. Review.

PMID:
28468570
35.

Progress Toward HHV-8 Prevention After Transplantation: In Search for Optimal Diagnostic Strategies.

Razonable RR.

Transplantation. 2017 Aug;101(8):1751-1752. doi: 10.1097/TP.0000000000001760. No abstract available.

PMID:
28376035
36.

Epidemiology, risk factors, and outcome of Clostridium difficile infection in heart and heart-lung transplant recipients.

Bruminhent J, Cawcutt KA, Thongprayoon C, Petterson TM, Kremers WK, Razonable RR.

Clin Transplant. 2017 Jun;31(6). doi: 10.1111/ctr.12968. Epub 2017 Apr 17.

PMID:
28314071
37.

Rhodococcus Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients1.

Vergidis P, Ariza-Heredia EJ, Nellore A, Kotton CN, Kaul DR, Morris MI, Kelesidis T, Shah H, Park SY, Nguyen MH, Razonable RR.

Emerg Infect Dis. 2017 Mar;23(3):510-512. doi: 10.3201/eid2303.160633.

38.

Epidemiology and risk factors for infection after living donor liver transplantation.

Abad CL, Lahr BD, Razonable RR.

Liver Transpl. 2017 Apr;23(4):465-477. doi: 10.1002/lt.24739.

39.

Treatment of alpha and beta herpesvirus infections in solid organ transplant recipients.

Abad CL, Razonable RR.

Expert Rev Anti Infect Ther. 2017 Feb;15(2):93-110. doi: 10.1080/14787210.2017.1266253. Epub 2016 Dec 12. Review.

PMID:
27911112
40.

Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials.

Ljungman P, Boeckh M, Hirsch HH, Josephson F, Lundgren J, Nichols G, Pikis A, Razonable RR, Miller V, Griffiths PD; Disease Definitions Working Group of the Cytomegalovirus Drug Development Forum.

Clin Infect Dis. 2017 Jan 1;64(1):87-91. Epub 2016 Sep 28.

PMID:
27682069
41.

Not the Usual Viral Suspects: Parvovirus B19, West Nile Virus, and Human T-Cell Lymphotrophic Virus Infections After Kidney Transplantation.

Razonable RR.

Semin Nephrol. 2016 Sep;36(5):428-434. doi: 10.1016/j.semnephrol.2016.05.019. Review.

PMID:
27772627
42.

α Herpes Virus Infections Among Renal Transplant Recipients.

Abad CL, Razonable RR.

Semin Nephrol. 2016 Sep;36(5):344-350. doi: 10.1016/j.semnephrol.2016.05.011. Review.

PMID:
27772619
43.

Screening for BK virus nephropathy in kidney transplant recipients: comparison of diagnostic tests.

Pinto GG, Poloni JA, Rotta LN, Razonable RR, Pasqualotto AC.

J Bras Nefrol. 2016 Jul-Sep;38(3):356-362. doi: 10.5935/0101-2800.20160054. English, Portuguese.

44.

Cytomegalovirus.

Dioverti MV, Razonable RR.

Microbiol Spectr. 2016 Aug;4(4). doi: 10.1128/microbiolspec.DMIH2-0022-2015. Review.

PMID:
27726793
45.

Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.

Hefazi M, Damlaj M, Alkhateeb HB, Partain DK, Patel R, Razonable RR, Gastineau DA, Al-Kali A, Hashmi SK, Hogan WJ, Litzow MR, Patnaik MM.

Transpl Infect Dis. 2016 Dec;18(6):913-920. doi: 10.1111/tid.12612. Epub 2016 Nov 11.

PMID:
27642723
46.

Unique characteristics of cryptococcosis identified after death in patients with liver cirrhosis: comparison with concurrent cohort diagnosed antemortem.

Singh N, Sifri CD, Silveira FP, Miller R, Gregg KS, Huprikar S, Lease ED, Zimmer A, Dummer JS, Spak CW, Koval C, Banach DB, Shroff M, Le J, Ostrander D, Avery R, Eid A, Razonable RR, Montero J, Blumberg E, Alynbiawi A, Morris MI, Randall HB, Alangaden G, Tessier J, Cacciarelli TV, Wagener MM, Sun HY.

Med Mycol. 2017 Apr 1;55(3):278-284. doi: 10.1093/mmy/myw079.

PMID:
27601609
47.

Non-tuberculous mycobacterial infections in solid organ transplant recipients: An update.

Abad CL, Razonable RR.

J Clin Tuberc Other Mycobact Dis. 2016 Apr 27;4:1-8. doi: 10.1016/j.jctube.2016.04.001. eCollection 2016 Aug. Review.

48.

Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative.

Beaird OE, Freifeld A, Ison MG, Lawrence SJ, Theodoropoulos N, Clark NM, Razonable RR, Alangaden G, Miller R, Smith J, Young JA, Hawkinson D, Pursell K, Kaul DR.

Transpl Infect Dis. 2016 Apr;18(2):210-5. doi: 10.1111/tid.12510. Epub 2016 Mar 29.

PMID:
26923867
49.

It's not too late: a proposal to standardize the terminology of "late-onset" cytomegalovirus infection and disease in solid organ transplant recipients.

Razonable RR, Blumberg EA.

Transpl Infect Dis. 2015 Dec;17(6):779-84. doi: 10.1111/tid.12447. Epub 2015 Nov 13. No abstract available.

PMID:
26771688
50.

Cytomegalovirus disease is associated with higher all-cause mortality after lung transplantation despite extended antiviral prophylaxis.

Beam E, Lesnick T, Kremers W, Kennedy CC, Razonable RR.

Clin Transplant. 2016 Mar;30(3):270-8. doi: 10.1111/ctr.12686. Epub 2016 Mar 1.

PMID:
26701733

Supplemental Content

Loading ...
Support Center